Background: The volume and outcome relationship for transplant procedures has become one of the major topics during discussions about consequences following the organ transplantation scandal of wait-list manipulations in Germany during the past year. Proponents of reducing the number of centers argue in favor of increasing quality at highly specialized transplant centers while disregarding the wish of patients for regionally available medical service.
Methods: The homepage of the German Organ Procurement Organization (DSO) was screened for the annual reports of transplant programs for the years 2007 to 2010. Results were extracted from these reports. Additionally, an analysis of volume per million people per number of transplant centers for each German federal state was made to give an overview of the density of transplant programs for the years 2009 to 2011.
Results: In-house mortality (R2 = 0.005, P = 0.518), 3-year survival (R2 = 0.068, P = 0.085), and a ROC analysis for in-house mortality (AUC 0.55, CI: 0.41; 0.68, P = 0.53), did not show volume-outcome relation. Definition of a threshold for good centers was impossible. One-year survival indicated better outcome in high volume centers. R2 = 0.106, P = 0.009. Outcome data in Germany, as provided by Institute für angewandte Qualitätsförderung und Forschung im Gesundheitswesen (AQUA) or the DSO, are not risk adapted for the investigated time period. The factor of transplants per year per million people per transplant centers is 0.6 for Germany. Some Federal States (for example, Bavaria and Northrhine Westfalia) have an oversupply of transplant centers, which means that the average number transplanted per center and year is very low.
Discussion and conclusion: We propose a risk-adapted prospective analysis of outcome and definition of a quality catalogue for liver transplant centers. Volume and outcome relation is not conclusive for liver transplantation in Germany. Data should be collected, for example, for a time period of 3 to 5 years, and decisions influencing the regulation of numbers of transplant centers should be based upon the findings, weighing federal state sovereignty and regional medical requirements against an optimal patient supply while respecting a plausible risk adaption for each center.